跳至主要内容
临床试验/NCT04541537
NCT04541537已完成不适用

Feasibility Study on the Possibility of Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

Institut Curie1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2021年1月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
To ascertain the possibilities to isolate the breast cancer olfactive signature

研究概览

简要总结

To ascertain the possibilities to isolate the breast cancer olfactive signature

详细描述

Patient recruitment during the first surgery consultation in Curie Institute.

Odor sampling (non-invasive) with an odor-sensing polymer (Sorbstar® polymer developed especially for the trace level analysis), on:

  • The hands, before and after surgical excision of the tumor (friction of the hands)
  • The diseased breast, before and after surgical excision of the tumor (via a compress positioned on the breast for 1 night)
  • The tumor, during the surgical procedure (odor collection over a tumor sample).

Each patient will be her own witness, before and after surgical excision, in an attempt to isolate the chemical signature tracks of breast cancer. The samples after surgery will be made after healing and before implementation of a treatment (chemotherapy and / or radiotherapy).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Diagnostic
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Patient received in surgery consultation for an invasive non metastatic breast cancer treated by breast-conserving surgery with axillary or sentinel node dissection
  • •Of-Age female patient (over 18 years old)
  • •Life expectancy > to 1 year at the inclusion
  • •ECOG performance status: 0 or 1 or 2
  • •Patient benefiting from the social security
  • •Signature informed consent of the study

排除标准

  • •Neoplasia in progress or neoplasia history of cancer other than breast to be treated.
  • •Wound presence on breasts
  • •Male subjects
  • •Pregnant or lactating women
  • •Specified metastatic breast cancer
  • •Concomitant medication taken one month before the surgical act (antibiotics, corticoids, anti-diabetics)
  • •Persons under guardianship or deprived of liberty
  • •Impossibility to submit to the medical monitoring expected by the study for geographical, social or psychological reasons.

研究组 & 干预措施

Sorbstar®

Experimental

Odour sampling : rub hands with Sorbstars® before and post-surgery

干预措施: Sorbstar® (Diagnostic Test)

Dog Detection

Experimental

Odour sampling :sleep over a night with a compress on the affected breast before and after surgery

干预措施: Dog Detection (Diagnostic Test)

结局指标

主要结局

To ascertain the possibilities to isolate the breast cancer olfactive signature

时间窗: 18 months

Isolation of volatile Organic Compounds to breast cancer by a sensitive technique with an odor-sensing polymer (Sorbstar®) on hands. Friction of the hands according to the protocol before and after surgical excision of the tumor. Sorbstar® analyses will be performed with a thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry.

次要结局

  • Ascertain breast cancer detection by the dogs of Curie Institut(18 months)
  • Ascertain breast cancer olfactive signature from the tumor (Isolation of volatile Organic Compounds to tumor breast samples by a sensitive technique with an odor-sensing polymer (Sorbstar®)(18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验